fscaresystems Viridex RF Bedienungsanleitung Seite 5

MANUEL
RF
IT USES A COLD LIGHT SOURCE AND FIBRE OPTIC CABLE. THE END OF THE FIBRE COMES INTO DIRECT CONTACT
WITH THE SKIN. THE LIGHT PASSING THROUGH THE SKIN IS REFLECTED BY THE FASCIA SUPERFICIALIS (DEEP
DERMIS) AND THE VEINS APPEAR AS CHINESE SHADOWS. IT CAN SHOW THE VEINS LOCATED ON THE DEEP SIDE
OF THE DERMIS. A TORTUOUS OR LOOPED APPEARANCE IS A SIGN OF A PATHOLOGY. .................................... 29
4. THE THERMOCOAGULATION ................................................................................................................. 30
4.1. P ....................................................................................................................................................... 30
RINCIPE
5. TREATEMENT PROTOCOLES .................................................................................................................. 31
5.1. T T
REATMENT OF ELANGIECTASIAS
5.1.1. Type of Needles.................................................................................................................................. 32
5.1.2. Systematic test before each pulse ..................................................................................................... 32
5.1.3. Verification of effectiveness ............................................................................................................... 32
5.1.4. Pragmatic approach .......................................................................................................................... 33
5.1.5. Evolution of the treatment ................................................................................................................ 33
5.1.6. Contra-indications ............................................................................................................................. 35
5.1.7. Advantage of Thermocoagulation ..................................................................................................... 35
5.1.8. Conclusion - Discussion ...................................................................................................................... 35
5.2. T H
REATMENT OF EMANGIOMA
5.3. T F
REATMENT OF IBROMAS
5.4. T A
REATMENT OF NGIOMA
5.5. T W
REATMENT OF RINKLES
5.6. T H
REATMENT OF AIR REMOVAL
5.7. T R
REATMENT OF OSACEA
5.8. E ............................................................................................................................................. 8
ND OF THE CARE
6. BESCHREIBUNG DES GERÄTES UND DER ZUBEHÖRTEILE............................................................................. 39
6.1. V V
ORDERSEITE DES
6.2. R V
ÜCKSEITE DES IRIDEX
6.3. Z ............................................................................................................................................ 40
UBEHÖRTEILE
6.3.1. Fußschalter ........................................................................................................................................ 40
6.3.2. Nadelhalter ........................................................................................................................................ 40
6.3.3. Nadeln ............................................................................................................................................... 40
6.3.4. Kopfbandlupe ..................................................................................................................................... 41
7. BENUTZUNG ............................................................................................................................................... 42
7.1. K
ONFIGURATION DES
7.1.1. Wahl einer Sprache ............................................................................................................................ 43
7.1.2. Bildschirmkontrast ............................................................................................................................. 43
7.1.3. Pause ................................................................................................................................................. 44
7.2. B V
ENUTZUNG DES IRIDEX
8. JÄHRLICHEN ÜBERPRÜFUNG ...................................................................................................................... 45
Date 27/03/2014
...................................................................................................................... 31
......................................................................................................................... 35
............................................................................................................................... 36
.............................................................................. F
............................................................................................................................... 36
....................................................................... F
............................................................................... F
RF ......................................................................................................................... 39
IRIDEX
RF............................................................................................................................. 39
V RF ....................................................................................................................... 43
RIDEX
RF ............................................................................................................................ 44
Page 5 de 49
THERMOCOAGULATION - Viridex
! B
OUT LADWIJZER NIET GEDEFINIEERD
! B
OUT LADWIJZER NIET GEDEFINIEERD
! B
OUT LADWIJZER NIET GEDEFINIEERD
.
.
.
N° de révision : 05